JO
TDAC

John Overdeck’s Translational Development Acquisition Corp TDAC Stock Holding History

John Overdeck’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-133,325
Closed -$1.41M – 5534
2026
Q1 		$1.41M Hold
133,325
– – ﹤0.01% 3013
2025
Q4 		$1.39M Hold
133,325
– – ﹤0.01% 2708
2025
Q3 		$1.38M Buy
+133,325
New +$1.38M ﹤0.01% 2372

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

John Overdeck's TDAC Position: Q2 2026 in Review

John Overdeck sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 133,325 shares — an estimated $1.41M sold.

John Overdeck first reported a position in TDAC in Q3 2025 and held it in 3 quarters. The position peaked at $1.41M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • John Overdeck reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 133,325 Translational Development Acquisition Corp shares in Q2 2026, an estimated $1.41M.
  • John Overdeck first reported a position in Translational Development Acquisition Corp in Q3 2025 and held it in 3 quarters.
  • John Overdeck's Translational Development Acquisition Corp position peaked at $1.41M in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.